301, E Square
Subhash Road Vile Parle (East)
Mumbai 400057
India
91 22 4084 2222
https://www.nglfinechem.com
Sector(s): Healthcare
Industry: Drug Manufacturers - General
Full Time Employees: 396
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Rahul Jayant Nachane | CEO, MD, Chief Ethics Counsellor & Executive Director | 15.99M | N/A | 1964 |
Mr. Rajesh Narayan Lawande | Whole Time Director & CFO | 15.84M | N/A | 1976 |
Ms. Pallavi Pednekar | Company Secretary & Compliance Officer | N/A | N/A | N/A |
Mr. Ahaan Nachane | Vice President | N/A | N/A | N/A |
NGL Fine-Chem Limited manufactures and sells pharmaceuticals and intermediates for use in veterinary and human health worldwide. It offers active pharmaceutical ingredients, such as diminazene aceturate, diminazene diaceturate, homidium chloride, nitroxynil, clorsulon, parvaquone, buparvaquone, isometamidium chloride hydrochloride, toldimfos sodium, butaphosphan, imidocarb dipropionate, triclabendazole, ractopamine HCl, S-methoprene, praziquantel, toltrazuril, decoquinate, flunixin meglumine, carprofen, fenbendazole, amitraz, xylazine hydrochloride, and marbofloxacin for animal health applications; and nitazoxanide and atovaquone for human health applications. The company provides various intermediate products and specialty chemicals; and finished dosage forms in granules and tablets. NGL Fine-Chem Limited was incorporated in 1981 and is based in Mumbai, India.
NGL Fine-Chem Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.